Company profile
Hart Biologicals | Your Partner in Haemostasis Testing
At the cutting edge of our sector and building on the success of the Manchester Capillary Reagent to become renowned partners in the global INR market
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzMjc2MjE2NGFkaXF6a2N4
Published 20 Aug 2024 14:13
Company registered at Companies House
1 Aug 2020 to 31 Mar 2023
To develop a Warfarin and DOAC (direct oral anticoagulant) test device for monitoring of patient drug levels with optimal quality and precision analysis, using a simple user interface, at a competitive price.
